Salbutamol (as Sulfate) - search results

juno pharmaceuticals corp. - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

New Zealand - English - Medsafe (Medicines Safety Authority)

respigen

viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg; - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg excipient: ethanol norflurane oleic acid - with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate and severe asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

salbutavent salbutamol (as sulfate) 2.5 mg/2.5 ml inhalation solution ampoule

medis pharma pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - inhalation - excipient ingredients: sodium chloride; sulfuric acid; water for injections - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

New Zealand - English - Medsafe (Medicines Safety Authority)

ventolin syrup

glaxosmithkline nz limited - salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml); - syrup - 2 mg/5ml - active: salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml) excipient: citric acid monohydrate hypromellose orange flavour 17-42-8187 purified water saccharin sodium sodium benzoate sodium chloride sodium citrate dihydrate - ventolin syrup is indicated for the treatment or prevention of bronchospasm. it provides short acting bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failing to respond to treatment with salbutamol may signal a need for urgent medical advice or treatment. ventolin syrup is suitable oral therapy for children or those adults who prefer liquid medicines.